Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Mediwelcome Healthcare Management & Technology (HKSE:02159) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Mediwelcome Healthcare Management & Technology's EV-to-EBIT for today is
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$9.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Mediwelcome Healthcare Management & Technology's EV-to-EBITDA for today is:
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$9.3 Mil.
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$515.6 Mil.
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$4.0 Mil.
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$3.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology Enterprise Value Related Terms
Mediwelcome Healthcare Management & Technology Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology Enterprise Value Chart
Mediwelcome Healthcare Management & Technology Annual Data
HKSE:02159 vs VEEV, BTSG, TEM: Enterprise Value Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology Enterprise Value vs Healthcare Providers & Services Industry
Mediwelcome Healthcare Management & Technology Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$362.5 Mil mean?
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Enterprise Value of HK$362.5 Mil as of Jul. 20, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Mediwelcome Healthcare Management & Technology and its competitors.
Is Mediwelcome Healthcare Management & Technology's Enterprise Value too high?
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Enterprise Value compare to VEEV and BTSG?
Mediwelcome Healthcare Management & Technology's Enterprise Value of HK$362.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$362.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.69, compared to a current price of HK$1.55 — trading 124.6% above its estimated fair value. The current Enterprise Value is HK$362.5 Mil. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Enterprise Value is HK$362.5 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.55 is trading 124.6% above its estimated GF Value™ of HK$0.69.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
Enterprise Value: HK$362.5 Mil
GF Value™: HK$0.69 vs. price of HK$1.55 (124.6% above fair value)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Business Description
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
56GF Score
Get the complete analysis for HKSE:02159
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
